Saturday, 24 October 2015

QBW251 - Warrington Guardian article from Saturday, 24 October 2015

Adam Everett, Reporter / Saturday, 24 October 2015 / News

Cystic fibrosis sufferer holds back tears as he tries breakthrough drug for the first time

Peter Trengove is taking part in the trial
of a new drug called QBW251

QBW251 could help reverse the effects of Cystic Fibrosis

A CYSTIC fibrosis suffered held back tears of happiness as he tried a new breakthrough drug for the first time.

Peter Trengrove suffers from the life-shortening inherited disease which is caused by a faulty gene, but the 36-year-old has become one of the first people to try QBW251 – a drug which could help reverse the effects caused by cystic fibrosis.

The Woolston resident has reported no side effects thus far, with people in the USA and Australia watching on via Peter’s live blogging of the trial.

On the blog Peter describes how he held back the tears as he tried the drug for the first time and described it as a new dawn.

Cystic fibrosis causes respiratory and digestive problems and the disease claimed Peter’s older brother’s life at the age of six, while Peter himself nearly died when he was just three days old because of it.

He said: “There’s a real excitement in the cystic fibrosis community about this drug.

“Since I started telling people on Facebook about this trial I've had people from the UK, USA and Australia contacting me asking about the trial drug and wishing me the best of luck.

“No one knows what’s going to happen so all eyes are on me for answers of this historic breakthrough - I feel I’ve become a celebrity.”

To keep up to date with Peter’s trial go to